openPR Logo
Press release

Hormonal Contraceptive Market Growing Trends and Business Opportunities by 2023

02-06-2020 08:23 AM CET | Health & Medicine

Press release from: Allied Market Research

Hormonal Contraceptive Market

Hormonal Contraceptive Market

Government initiatives to promote awareness of the benefits of family planning and contraception, and advances in hormonal contraceptive techniques and methods for improving efficiency and developing products with fewer side effects, are key drivers of market growth.

Hormonal Contraceptive Market is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023.

North America is the highest contributor in the hormonal contraceptive market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Hormonal contraception acts on the endocrine system to prevent unwanted pregnancy. Synthetic forms of naturally occurring hormones such as progestin and estrogen are used to prevent ovulation and avoid fertilization. These forms of birth control methods also change the environment of the uterus, making it unfavorable for fertilization.

Hormonal contraceptives are available in a variety of forms such as patches, pill, injection, and rings, which are safe and reliable forms of hormonal contraceptives to prevent pregnancy.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4574

The major driving factors of the hormonal contraceptive market are an increase in focus towards family planning, health issues associated with teenage pregnancies, an increase in awareness about modern contraception methods, and a rise in the use of oral pills as a key method to prevent unplanned pregnancy.

The advancement in hormonal contraception with better efficacy and fewer side effects further boost the market growth. However, the availability of alternative contraceptive methods, health risks associated with the use of contraceptives, and lack of social acceptance adversely affect market growth.

Among the product, the oral contraceptive pill is the dominant segment, as these pills are easily available and have a high success rate of up to 99% to prevent pregnancy. However, the vaginal ring registers the highest growth rate, due to the ease of usage and fewer side effects caused by it.

Combined hormonal contraceptive is the dominant segment in the hormonal contraceptive market, due to the wide availability of combined hormonal contraceptive along with better efficiency to prevent pregnancy.

In 2016, North America was the major revenue generator, owing to an increase in awareness towards the benefits of using hormonal contraceptives, high prevalence of unwanted pregnancy, and favorable regulatory scenario.

However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, due to the presence of populace countries such as India and China where there is a greater need to control the growing population.

The key players operating in the global hormonal contraceptive market include the Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc., Mylan N.V., Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc., and Church & Dwight, Co., Inc.

Other prominent players in the value chain include Reckitt Benckiser Plc., Warner Chilcott Company, BioSante Pharmaceuticals Inc., HLL Lifecare Limited, Boehringer Ingelheim GmbH, Watson Pharmaceuticals, Inc., V-Care Pharma Pvt. Ltd., Vardhman Life Care Pvt. Ltd., Cipla Limited, and others.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4574

Key Findings of the Hormonal Contraceptive Market:
o Vaginal rings are projected to grow at the highest rate during the analysis period.
o North America dominated the global hormonal contraceptive market in 2016 and is projected to continue its dominance in the future.
o China is expected to grow at the highest rate in the Asia-Pacific region during the forecast period.
o Hospitals are the largest contributor among the end-user segments in 2016.
o The 15-24 years age group segment generated the highest revenue and is expected to continue its dominance in the future.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975

help@alliedmarketresearch.com

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hormonal Contraceptive Market Growing Trends and Business Opportunities by 2023 here

News-ID: 1921138 • Views: 218

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Hormonal

Hormonal Replacement Therapeutics - Pipeline Analysis 2018 | Novo Nordisk
Hormonal replacement therapy is a type of treatment wherein patients receive a course of hormones in order to get relieve from the menopause related problems. The therapy involves administration of synthetic estrogen and progesterone to overcome decreasing hormone level of women. Download the sample report @ https://www.pharmaproff.com/request-sample/1136 The most common signs and symptoms observed in patients with decreased hormone level are irregular menstrual cycles, and psychological symptoms (mood swings, anxiety, and
Global Hormonal Therapy Industry Market Analysis & Forecast 2018-2023
Global Hormonal Therapy Industry Market is divided into treatment type, dispersion channel, and application. Based on the treatment type, the worldwide market is isolated into estrogen substitution treatment, thyroid hormone substitution, and development hormone substitution. The thyroid hormone substitution portion is further sub-fragmented into tablets, infusions, and cases. Get sample copy of report: https://www.marketdensity.com/contact?ref=Sample&reportid=4477 Table of Contents Chapter 1 Hormonal Therapy Market Overview 1.1 Product Overview and Scope of Hormonal Therapy 1.2 Hormonal
Hormonal Contraception Market: Information, Figures and Analytical Insights 2016 …
Hormonal contraception is type of pregnancy prevention techniques which act on the endocrine system. In this method various female hormones are used to prevent ovulation. Two forms of hormonal contraceptive formulations are available in combination forms such as estrogen and a progestin. However, progestogen is the only method which contains progesterone or any one of its synthetic analogues. In combination method the therapeutic effect is achieved by suppressing ovulation and
Somatostatin Receptor Market For Hormonal Disorder, Oncology, Metabolic Disorder
MarketResearchReports.Biz adds “Global Somatostatin Receptor Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Somatostatin Receptor and the growth estimates for the forecasted period. This report studies the Somatostatin Receptor Type 2 market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global
High Awareness in Female Population Regarding Hormonal Disorders Drives the Pres …
Global Prescription Hormonal Drugs Market in Gynecology: Description Hormonal imbalance in women is caused due to abnormalities in the secretion of estrogen, progesterone and as well as androgens. A wide array of symptoms might be experienced by patients depending on the type of abnormality such as hot flushes, depression, vaginal dryness, excessive hair growth and abnormal vaginal bleeding. Environmental and genetic factors have an influence on women's fertility through their effect
Global Hormonal Contraceptives Market - Allergan, Merck Millipore, Pfizer & Teva …
The Market N Reports report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Hormonal Contraceptives market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who are in need